Skip to main content
. 2020 Dec 26;36(3):794–807. doi: 10.1093/humrep/deaa324

Table I.

Select characteristics and exposure summaries for participants from the Seveso Women’s Health Study and Seveso Second Generation Study, Seveso, Italy, 1976–2016.

SWHS
Second generation daughters
N (%) Initial 1976 TCDD
Median (IQR)
Estimated TCDD at pregnancy
Median (IQR)
N (%) Maternal initial 1976 TCDD
Median (IQR)
Estimated TCDD in utero
Median (IQR)
Total 446 (100) 61.4 (29.2–174.0) 12.8 (6.2–31.3) 66 (100) 52.8 (27.0–128.0) 35.8 (19.5–85.8)
Age at explosion (years)
 0–10 143 (32.1) 162.0 (55.9–327.0) 5.7 (3.0–10.5)
 11–20 193 (43.3) 52.6 (26.7–109.0) 14.4 (8.3–30.6)
 21–30 102 (22.9) 41.6 (22.2–90.1) 31.1 (17.5–69.4)
 30–40 8 (1.8) 32.4 (25.4–88.4) 32.9 (20.0–62.9)
Parity at time of explosion
 Nulliparous 371 (83.2) 70.0 (31.7–206.0) 10.9 (5.5–26.4)
 Parous 75 (16.8) 38.5 (22.2–86.2) 30.6 (17.5–69.4)
Age at pregnancy attempt (years)
 <25 126 (28.3) 46.4 (23.2–100.0) 19.1 (10.3–39.1) 8 (12.1) 86.3 (14.8–221.0) 24.4 (10.8–91.0)
 25–29 192 (43.1) 63.2 (28.2–180.4) 12.4 (6.4–31.4) 34 (51.5) 57.8 (35.5–105.0) 36.1 (21.8–83.7)
 30–34 98 (22.0) 92.3 (41.9–220.0) 8.1 (3.7–18.6) 22 (33.3) 37.7 (22.5–126.0) 34.6 (19.5–85.8)
 ≥35 30 (6.7) 139.4 (35.8–245.0) 7.3 (4.9–19.6) 2 (3.0) 127.85 (64.7–191) 127.85 (64.7–191)
Marital status
 Married/living as married 380 (85.2) 40.4 (22.5–140.0) 15.1 (8.2–37.1) 61 (92.4) 54.3 (29.9–128.0) 35.8 (21.3–85.8)
 Not married/living as married 66 (14.8) 64.0 (31.7–178.0) 12.0 (6.0–31.1) 5 (7.6) 19.5 (18.4–68.6) 19.5 (18.4–68.6)
Education
 Less than high school 103 (23.1) 62.4 (23.9–212.0) 26.2 (9.0–49.9) 13 (19.7) 37.7 (35.5–128.0) 35.5 (25.7–70.4)
 High school or technical 322 (72.2) 60.3 (29.9–166.0) 11.2 (6.0–26.4) 40 (60.6) 47.0 (24.5–133.5) 35.3 (18.6–107.1)
 Bachelor’s degree or higher 21 (4.7) 75.7 (30.2–192.0) 6.3 (3.4–12.9) 13 (19.7) 72.0 (19.5–105.0) 56.5 (19.5–72.7)
Smoked in year before
 No 332 (74.4) 61.8 (31.4–189.0) 12.2 (5.7–31.4) 46 (69.7) 48.5 (25.1–185.0) 37.8 (19.5–106.1)
 Yes 114 (25.6) 61.3 (23.3–157.0) 13.7 (7.2–31.0) 20 (30.3) 57.8 (32.9–88.4) 35.1 (19.7–67.1)
OC use in year before
 No 350 (78.5) 61.1 (28.9–180.0) 11.9 (5.7–30.4) 52 (78.8) 44.0 (24.5–94.7) 34.6 (18.6–66.7)
 Yes 96 (21.5) 69.6 (37.2–165.0) 17.3 (7.9–32.5) 14 (21.2) 133.5 (61.3–245.0) 106.9 (35.8–117.0)
Menstrual cycle
 Regular 400 (89.7) 62.6 (29.5–182.5) 13.5 (6.3–31.7) 55 (83.3) 51.3 (23.9–126.0) 34.8 (18.8–70.4)
 Irregular 46 (10.3) 54.3 (22.0–148.0) 9.5 (3.9–26.0) 11 (16.7) 99.5 (37.5–238.0) 72.7 (35.5–112.7)
History of reproductive or endocrine conditions
 No 381 (85.4) 60.1 (29.0–163.0) 14.1 (6.8–32.0) 59 (89.4) 51.3 (27.0–135.0) 35.8 (19.5–88.9)
 Yes 65 (14.6) 98.9 (42.2–264.0) 7.7 (3.2–15.0) 7 (10.6) 54.3 (22.5–126.0) 35.7 (18.8–85.8)

IQR, interquartile range; OC, oral contraceptive; SWHS, Seveso Women’s Health Study; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin.